Suominen (SUY1V) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
12 May, 2026Executive summary
Net sales for Q1 2026 declined 19% year-over-year to EUR 95.6 million, mainly due to lower volumes, currency effects, and lingering impacts from U.S. plant incidents in 2025.
Comparable EBITDA dropped to EUR 2.2 million from EUR 4.1 million, but improved slightly from Q4 2025.
Cash flow from operations improved to EUR 4.5 million, supported by working capital improvements and increased factoring.
A comprehensive three-year Full Potential Program was launched in January 2026 to restore profitability, targeting a 10% EBITDA margin by 2028.
A new operating model was adopted to enhance customer focus and manufacturing effectiveness.
Financial highlights
Net sales in Q1 2026 were EUR 95.6 million, reflecting lower volumes and a EUR -5.6 million currency impact.
Comparable EBITDA for Q1 2026 was EUR 2.2 million, down from EUR 4.1 million in Q1 2025.
Cash flow from operations improved to EUR 4.5 million, compared to EUR -0.4 million in Q1 2025, supported by a EUR 6.2 million positive change in net working capital.
Operating profit for Q1 2026 was EUR -4.4 million, with a net loss of EUR -5.7 million and EPS of EUR -0.10.
Share of new products in net sales was 26%, with a negative mix impact on profit.
Outlook and guidance
Comparable EBITDA is expected to increase in 2026 compared to 2025 (EUR 12.6 million in 2025).
The Full Potential Program aims to raise EBITDA margin from 3% to 10% by 2028 and reduce leverage to 2x–3x net debt/EBITDA.
Volume outlook for the rest of 2026 is higher than Q1, with order intake recovering, especially in the U.S.
Alicante line in Spain will start commercial production in May, with incremental margin benefits expected in H2 2026 and 2027.
Latest events from Suominen
- EBITDA rose to EUR 17 million, with 2025 outlook positive and major investments ongoing.SUY1V
Q4 202430 Mar 2026 - 2025 saw steep sales and profit declines, but turnaround efforts and cash flow gains support 2026 recovery.SUY1V
Q4 20253 Feb 2026 - Q3 sales up 5%, but operational issues cut profit; 2024 EBITDA is set to surpass last year.SUY1V
Q3 202416 Jan 2026 - Q2 2025 saw lower sales and EBITDA, but cost savings and new leadership target recovery.SUY1V
Q2 202523 Nov 2025 - Net sales up 3.4%, EBITDA down; cost-saving and sustainability drive 2025 outlook.SUY1V
Q1 202520 Nov 2025 - Profitability and sales fell on US plant incidents; full-year EBITDA guidance was reduced.SUY1V
Q3 202530 Oct 2025 - Q2 2024 saw higher sales and EBITDA, with restructuring and sustainability investments boosting outlook.SUY1V
Q2 202413 Jun 2025